Hapvida Participações e Investimentos (HAPV3) Stock Overview
Operates in the healthcare sector in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
HAPV3 Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Hapvida Participações e Investimentos S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$11.59 |
| 52 Week High | R$42.66 |
| 52 Week Low | R$7.00 |
| Beta | 0.29 |
| 1 Month Change | -9.03% |
| 3 Month Change | 33.68% |
| 1 Year Change | -69.89% |
| 3 Year Change | -82.24% |
| 5 Year Change | -95.02% |
| Change since IPO | -86.61% |
Recent News & Updates
Narrative Update • Jun 04
HAPV3: Contract Repricing And Margin Recovery Will Support Bullish Reset
Analysts have slightly reduced the fair value estimate for Hapvida Participações e Investimentos to about R$18.82 from R$19.00. This reflects updated assumptions for discount rates, growth, margins, and future P/E in light of mixed recent ratings changes and expectations around contract repricing.Narrative Update • May 19
HAPV3: Contract Repricing Will Reshape Margins And Support Future Upside
Analysts have reset their price target for Hapvida Participações e Investimentos to R$19 from R$26.16, reflecting a higher discount rate, more cautious assumptions on revenue growth and profit margins, and a higher future P/E multiple as they factor in both recent operational issues and expected benefits from contract repricing. Analyst Commentary Recent Street research shows a split view on Hapvida Participações e Investimentos, with some firms turning more cautious while others highlight potential upside as contract repricing and internal adjustments progress.Recent updates
Narrative Update • Jun 04
HAPV3: Contract Repricing And Margin Recovery Will Support Bullish Reset
Analysts have slightly reduced the fair value estimate for Hapvida Participações e Investimentos to about R$18.82 from R$19.00. This reflects updated assumptions for discount rates, growth, margins, and future P/E in light of mixed recent ratings changes and expectations around contract repricing.Narrative Update • May 19
HAPV3: Contract Repricing Will Reshape Margins And Support Future Upside
Analysts have reset their price target for Hapvida Participações e Investimentos to R$19 from R$26.16, reflecting a higher discount rate, more cautious assumptions on revenue growth and profit margins, and a higher future P/E multiple as they factor in both recent operational issues and expected benefits from contract repricing. Analyst Commentary Recent Street research shows a split view on Hapvida Participações e Investimentos, with some firms turning more cautious while others highlight potential upside as contract repricing and internal adjustments progress.Narrative Update • May 02
HAPV3: Lower Future P/E And Integration Progress Will Support Upside Potential
Analysts have trimmed their fair value estimate for Hapvida Participações e Investimentos from about R$28.39 to roughly R$26.16, with recent downgrades citing updated views on growth, profitability, discount rates and future P/E assumptions. Analyst Commentary Recent research has focused on reassessing Hapvida Participações e Investimentos in light of updated expectations for growth, profitability and valuation multiples.
Narrative Update • Apr 18
HAPV3: Goldman Downgrade And Margin Pressures Will Limit Future Share Upside
Analysts now hold a flat R$7.00 price target for Hapvida Participações e Investimentos, with the unchanged fair value supported by updated assumptions on discount rates, revenue growth, profit margins and future P/E, even as recent Street research, including a downgrade from a major global bank, has led to a more cautious stance on the shares. Analyst Commentary Recent Street research, including a downgrade from Goldman Sachs, points to a more cautious tone around Hapvida Participações e Investimentos, even with the flat R$7.00 price target.Narrative Update • Apr 04
HAPV3: Downgrade And Margin Concerns Will Constrain Future Upside Potential
Analysts have cut their price target on Hapvida Participações e Investimentos from R$15.00 to R$7.00, citing updated assumptions for the discount rate, revenue growth, profit margins and future P/E following recent research, including a downgrade from a major global bank. Analyst Commentary Recent sell side research around Hapvida Participações e Investimentos points to a more cautious tone, with the reduced price target to R$7.00 framed as a reassessment of risk rather than a simple valuation tweak.Narrative Update • Mar 21
HAPV3: Index Reclassification And Lower Future P/E Will Support Upside
Analysts have lowered their price target for Hapvida Participações e Investimentos to R$28.39 from R$49.96, citing updated assumptions on discount rates, revenue growth, profit margins, and a revised future P/E of 13.04x. What's in the News Hapvida Participações e Investimentos S.A. has been added to the Brazil Small Cap Index, which may affect how index and small cap focused funds view the stock (Key Developments).Narrative Update • Mar 07
HAPV3: Index Shift And Higher Future P/E Will Support Upside
Analysts have kept their R$15.00 price target for Hapvida Participações e Investimentos unchanged, citing slightly revised assumptions for the discount rate, revenue growth, profit margin, and future P/E to reflect a more balanced risk and earnings outlook. What's in the News Hapvida Participações e Investimentos S.A. has been added to the Brazil Small Cap Index, indicating inclusion in a benchmark that tracks smaller listed companies (Key Developments).Narrative Update • Feb 20
HAPV3: Index Reclassification Will Support Future Upside From Lower Expected P/E
Analysts have trimmed their price target for Hapvida Participações e Investimentos from R$18.50 to R$15.00, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations in their valuation work. What's in the News Hapvida Participações e Investimentos S.A. has been added to the Brazil Small Cap Index, which can affect how index funds and small cap mandates gain exposure to the stock (Key Developments).
Narrative Update • Feb 06
HAPV3: Index Reclassification And Higher Risk Assumptions Will Create Future Upside Potential
Analysts have trimmed their price target for Hapvida Participações e Investimentos from R$30.69 to R$26.09, as they now assume a slightly higher discount rate, slightly softer revenue growth and profit margins, and a lower future P/E multiple in their models. What's in the News Hapvida Participações e Investimentos S.A. has been removed from the Brazil Mid-Large Cap Index, which may change how some index-linked funds are exposed to the stock (Key Developments).Analysis Article • Feb 06
Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Unfortunately for some shareholders, the Hapvida Participações e Investimentos S.A. ( BVMF:HAPV3 ) share price has...Analysis Article • Jan 28
Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Narrative Update • Jan 23
HAPV3: Index Reclassification And Higher Future P/E Will Support Upside
Analysts have trimmed their price target for Hapvida Participações e Investimentos slightly to about R$49.96 from R$50.00, citing updated assumptions for revenue growth, profit margins, and a higher future P/E multiple in their models. What's in the News Hapvida Participações e Investimentos S.A. has been added to the Brazil Small Cap Index, which can affect how index and small cap focused funds view the stock (Key Developments).Narrative Update • Jan 09
HAPV3: Index Reclassification And Earnings Multiple Will Support Future Upside
Analysts have trimmed their price target on Hapvida Participações e Investimentos to R$18.50 from R$21.00, citing revised fair value assumptions that include adjustments to discount rates, revenue growth expectations, profit margins and future P/E estimates. What's in the News Hapvida Participações e Investimentos S.A. was added to the Brazil Small Cap Index, reflecting its current classification within Brazilian equity indices (Key Developments).Narrative Update • Dec 26
HAPV3: Higher Risk Premium Will Still Support Attractive Upside Potential
Analysts have reduced their price target for Hapvida Participações e Investimentos from R$85.44 to R$50.00, citing expectations for slower revenue growth, thinner profit margins, a higher perceived risk profile, and a lower justified future price to earnings multiple. Valuation Changes The fair value estimate was reduced significantly from R$85.44 to R$50.00, reflecting a materially lower assessment of long term intrinsic value.Narrative Update • Dec 12
HAPV3 Will Offer Upside As Earnings Multiple Remains Supportive
Analysts have reduced their 12 month price target for Hapvida Participações e Investimentos from R$31.85 to R$21.00. This reflects more conservative assumptions on discount rates, revenue growth and profit margins, while still expecting the stock to trade on a relatively supportive forward price to earnings multiple.Narrative Update • Nov 27
HAPV3: Lower Discount Rate Outlook Will Drive Future Upside Potential
Analysts have lowered their price target for Hapvida Participações e Investimentos from R$54.46 to R$30.69. This adjustment is based on expectations for slower revenue growth, slightly higher discount rates, and narrower profit margins.Analysis Article • Nov 14
Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Share Price Is Still Matching Investor Opinion Despite 43% Slump
The Hapvida Participações e Investimentos S.A. ( BVMF:HAPV3 ) share price has fared very poorly over the last month...Narrative Update • Nov 13
HAPV3 Will Benefit From Marginally Higher Revenue Growth and Favorable Discount Rate Shift
Analysts have revised their price target for Hapvida Participações e Investimentos downward by R$1.00 to R$54.46. This change reflects minor adjustments in discount rates, projected revenue growth, and profit margin forecasts.Narrative Update • Oct 30
Urban Clinic Expansion And AI Integration Will Transform Brazilian Healthcare
Analysts have slightly reduced their price target for Hapvida Participações e Investimentos, lowering it by R$0.19 to R$55.46 as they factor in minor adjustments in expected growth and profitability metrics. Valuation Changes Fair Value: Decreased slightly from R$55.65 to R$55.46.Narrative Update • Oct 15
Urban Clinic Expansion And AI Integration Will Transform Brazilian Healthcare
Hapvida Participações e Investimentos saw its analyst price target decrease from R$59.04 to R$55.65. Analysts cited updated assumptions for discount rates, revenue growth, and projected profitability margins.Analysis Article • Sep 29
These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Narrative Update • Sep 15
Urban Clinic Expansion And AI Integration Will Transform Brazilian Healthcare
Hapvida Participações e Investimentos saw a slight increase in its future P/E ratio, reflecting marginally improved growth expectations, which contributed to a minor upward revision in its consensus analyst price target from R$57.93 to R$59.04. Valuation Changes Summary of Valuation Changes for Hapvida Participações e Investimentos The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from R$57.93 to R$59.04.Analysis Article • Aug 31
Investors Appear Satisfied With Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Prospects As Shares Rocket 28%
Those holding Hapvida Participações e Investimentos S.A. ( BVMF:HAPV3 ) shares would be relieved that the share price...Analysis Article • Jul 01
These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Apr 18
Getting In Cheap On Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Is Unlikely
It's not a stretch to say that Hapvida Participações e Investimentos S.A.'s ( BVMF:HAPV3 ) price-to-sales (or "P/S...Analysis Article • Mar 17
These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
New Narrative • Dec 20
Brazilian Healthcare Expansion And Tech Investments Will Drive Growth And Boost Margins
Expansion and upgrades of healthcare infrastructure in Brazil may drive growth in membership and revenue.Analysis Article • Dec 18
Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Stocks Pounded By 28% But Not Lagging Industry On Growth Or Pricing
To the annoyance of some shareholders, Hapvida Participações e Investimentos S.A. ( BVMF:HAPV3 ) shares are down a...Analysis Article • Dec 16
Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Nov 19
Hapvida Participações e Investimentos' (BVMF:HAPV3) Performance Is Even Better Than Its Earnings Suggest
Hapvida Participações e Investimentos S.A. ( BVMF:HAPV3 ) just reported healthy earnings but the stock price didn't...Analysis Article • Nov 15
Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Shareholders might have noticed that Hapvida Participações e Investimentos S.A. ( BVMF:HAPV3 ) filed its third-quarter...Analysis Article • Jul 16
Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Apr 28
Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Popularity With Investors Is Under Threat From Overpricing
There wouldn't be many who think Hapvida Participações e Investimentos S.A.'s ( BVMF:HAPV3 ) price-to-sales (or "P/S...Analysis Article • Mar 28
Is Hapvida Participações e Investimentos (BVMF:HAPV3) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Jan 07
Investors Still Waiting For A Pull Back In Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)
There wouldn't be many who think Hapvida Participações e Investimentos S.A.'s ( BVMF:HAPV3 ) price-to-sales (or "P/S...Analysis Article • Dec 11
Hapvida Participações e Investimentos (BVMF:HAPV3) Is Making Moderate Use Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Sep 11
Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Jun 08
Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Shareholder Returns
| HAPV3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 5.9% | 3.6% | 1.6% |
| 1Y | -69.9% | -7.0% | 12.2% |
Return vs Industry: HAPV3 underperformed the BR Healthcare industry which returned -10.5% over the past year.
Return vs Market: HAPV3 underperformed the BR Market which returned 10% over the past year.
Price Volatility
| HAPV3 volatility | |
|---|---|
| HAPV3 Average Weekly Movement | 10.6% |
| Healthcare Industry Average Movement | 7.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in BR Market | 7.8% |
| 10% least volatile stocks in BR Market | 1.9% |
Stable Share Price: HAPV3's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: HAPV3's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | n/a | Luccas Adib | ri.hapvida.com.br |
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. Hapvida Participações e Investimentos S.A. was founded in 1979 and is headquartered in Fortaleza, Brazil.
Hapvida Participações e Investimentos S.A. Fundamentals Summary
| HAPV3 fundamental statistics | |
|---|---|
| Market cap | R$5.51b |
| Earnings (TTM) | -R$428.85m |
| Revenue (TTM) | R$31.85b |
0.2x
P/S Ratio-12.8x
P/E RatioIs HAPV3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HAPV3 income statement (TTM) | |
|---|---|
| Revenue | R$31.85b |
| Cost of Revenue | R$28.18b |
| Gross Profit | R$3.67b |
| Other Expenses | R$4.10b |
| Earnings | -R$428.85m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Aug 12, 2026
| Earnings per share (EPS) | -0.90 |
| Gross Margin | 11.52% |
| Net Profit Margin | -1.35% |
| Debt/Equity Ratio | 28.2% |
How did HAPV3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/12 12:21 |
| End of Day Share Price | 2026/06/11 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hapvida Participações e Investimentos S.A. is covered by 17 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Bertan | BB Banco de Investimento S.A. |
| Flavio Yoshida | BofA Global Research |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |